Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Flebogamma DIF
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flebogamma DIF 10g/100ml solution for infusion vials
1405010A0BUAFBQ
|
Flebogamma DIF | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Flebogamma DIF 10g/200ml solution for infusion vials
1405010A0BUADAC
|
Flebogamma DIF | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Flebogamma DIF 2.5g/50ml solution for infusion vials
1405010A0BUABAL
|
Flebogamma DIF | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Flebogamma DIF 20g/200ml solution for infusion vials
1405010A0BUAGBR
|
Flebogamma DIF | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Flebogamma DIF 20g/400ml solution for infusion vials
1405010A0BUAEBT
|
Flebogamma DIF | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Flebogamma DIF 500mg/10ml solution for infusion vials
1405010A0BUAAAA
|
Flebogamma DIF | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Flebogamma DIF 5g/100ml solution for infusion vials
1405010A0BUACAN
|
Flebogamma DIF | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
|
Flebogamma DIF 5g/50ml solution for infusion vials
1405010A0BUAHBP
|
Flebogamma DIF | Normal immunoglobulin (Gamma globulin) | Immunological Products and Vaccines | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.